Autoantibodies for IFNα, IFNκ, or both found in 101 of 987 patients with life-threatening pneumonia, none in 663 patients with no or mild symptoms, 4 of 1227 healthy patients. This evidence concerns the gene IFNA2 and susceptibility to pneumonia measurement.